These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23402905)

  • 1. Anti-tumorigenic action of 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b)pyran: evidence for involvement of GPR30/EGFR signaling pathway.
    Chandra V; Fatima I; Saxena R; Hussain MK; Hajela K; Sankhwar P; Roy BG; Chandna S; Dwivedi A
    Gynecol Oncol; 2013 May; 129(2):433-42. PubMed ID: 23402905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2,3-Diaryl-2H-1-benzopyran derivatives interfere with classical and non-classical estrogen receptor signaling pathways, inhibit Akt activation and induce apoptosis in human endometrial cancer cells.
    Fatima I; Chandra V; Saxena R; Manohar M; Sanghani Y; Hajela K; Negi MP; Sankhwar PL; Jain SK; Dwivedi A
    Mol Cell Endocrinol; 2012 Jan; 348(1):198-210. PubMed ID: 21878365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-proliferative effect of 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b) pyran is potentiated via induction of estrogen receptor beta and p21 in human endometrial adenocarcinoma cells.
    Fatima I; Saxena R; Kharkwal G; Hussain MK; Yadav N; Hajela K; Sankhwar PL; Dwivedi A
    J Steroid Biochem Mol Biol; 2013 Nov; 138():123-31. PubMed ID: 23688837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways.
    Saxena R; Chandra V; Manohar M; Hajela K; Debnath U; Prabhakar YS; Saini KS; Konwar R; Kumar S; Megu K; Roy BG; Dwivedi A
    PLoS One; 2013; 8(6):e66246. PubMed ID: 23840429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of 2-(piperidinoethoxyphenyl)-3-(4-hydroxyphenyl)-2H-benzo(b)pyran (K-1) on human primary endometrial hyperplasial cells mediated via combined suppression of Wnt/β-catenin signaling and PI3K/Akt survival pathway.
    Chandra V; Fatima I; Manohar M; Popli P; Sirohi VK; Hussain MK; Hajela K; Sankhwar P; Dwivedi A
    Cell Death Dis; 2014 Aug; 5(8):e1380. PubMed ID: 25144715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis induction and inhibition of hyperplasia formation by 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b)pyran in rat uterus.
    Chandra V; Fatima I; Saxena R; Kitchlu S; Sharma S; Hussain MK; Hajela K; Bajpai P; Dwivedi A
    Am J Obstet Gynecol; 2011 Oct; 205(4):362.e1-11. PubMed ID: 21782150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.
    Ge X; Guo R; Qiao Y; Zhang Y; Lei J; Wang X; Li L; Hu D
    Int J Gynecol Cancer; 2013 Jan; 23(1):52-9. PubMed ID: 23235274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of PD98059 and LY294002 on subcutaneous xenograft of human endometrial carcinoma in nude mice].
    Guo RX; Zhang RF; Wang XY; Shi HR; Qiao YH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):446-52. PubMed ID: 21781587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.
    Wei Y; Zhang Z; Liao H; Wu L; Wu X; Zhou D; Xi X; Zhu Y; Feng Y
    Oncol Rep; 2012 Feb; 27(2):504-10. PubMed ID: 22075757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-implantation effect of 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b)pyran, a potent antiestrogenic agent in rats.
    Kharkwal G; Fatima I; Kitchlu S; Singh B; Hajela K; Dwivedi A
    Fertil Steril; 2011 Mar; 95(4):1322-7. PubMed ID: 20674906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor signaling pathway involved in progestin-resistance of human endometrial carcinoma: In a mouse model.
    Xu Y; Tong J; Ai Z; Wang J; Teng Y
    J Obstet Gynaecol Res; 2012 Dec; 38(12):1358-66. PubMed ID: 22612393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G Protein-Coupled Receptor 30 Mediates the Anticancer Effects Induced by Eicosapentaenoic Acid in Ovarian Cancer Cells.
    Zhao Y; Zhao MF; Yang ML; Wu TY; Xu CJ; Wang JM; Li CJ; Li X
    Cancer Res Treat; 2020 Jul; 52(3):815-829. PubMed ID: 32138466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
    Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
    Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells.
    Vivacqua A; Romeo E; De Marco P; De Francesco EM; Abonante S; Maggiolini M
    Breast Cancer Res Treat; 2012 Jun; 133(3):1025-35. PubMed ID: 22147081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progestin treatment decreases CD133+ cancer stem cell populations in endometrial cancer.
    Guy MS; Qamar L; Behbakht K; Post MD; Sheeder J; Sartorius CA; Spillman MA
    Gynecol Oncol; 2016 Mar; 140(3):518-26. PubMed ID: 26731726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphenol A promotes the proliferation of leiomyoma cells by GPR30-EGFR signaling pathway.
    Li Z; Lu Q; Ding B; Xu J; Shen Y
    J Obstet Gynaecol Res; 2019 Jul; 45(7):1277-1285. PubMed ID: 31016847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (-)-Epigallocatechin-3-gallate induces apoptosis in human endometrial adenocarcinoma cells via ROS generation and p38 MAP kinase activation.
    Manohar M; Fatima I; Saxena R; Chandra V; Sankhwar PL; Dwivedi A
    J Nutr Biochem; 2013 Jun; 24(6):940-7. PubMed ID: 22959059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibiting effect of letrozole combined with curcumin on xenografted endometrial carcinoma growth in nude mice].
    Liang YJ; Zhang HM; Wu YZ; Hao Q; Wang JD; Hu YL
    Chin J Cancer; 2010 Jan; 29(1):9-14. PubMed ID: 20038303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line.
    Lu YY; Jing DD; Xu M; Wu K; Wang XP
    World J Gastroenterol; 2008 Sep; 14(35):5403-11. PubMed ID: 18803351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.